Gastrointestinal Pathophysiology - USMLE Step 1

SECTION 1

Historical Context & Motivation

The study of gastrointestinal pathophysiology has evolved dramatically over the past two centuries, transforming from vague clinical descriptions of "dyspepsia" and "flux" into a precise molecular and cellular science. Early physicians recognized that the gut was central to health—Hippocrates himself declared that "all disease begins in the gut"—but the mechanisms underlying GI disorders remained elusive until advances in microbiology, endoscopy, and molecular biology converged to illuminate the pathways of disease. Understanding these historical landmarks is essential for appreciating why modern classification of GI pathology emphasizes mechanism-based reasoning rather than purely descriptive phenomenology, a perspective that is heavily tested on the USMLE Step 1 examination.

1833 • William Beaumont & Gastric Physiology

Beaumont's experiments on Alexis St. Martin's gastric fistula provided the first direct observations of gastric acid secretion, mucosal appearance during digestion, and the effects of emotional stress on the stomach—laying the groundwork for understanding acid-peptic disease.

1932 • Crohn's Description of Regional Ileitis

Burrill Crohn, Leon Ginzburg, and Gordon Oppenheimer published their landmark description of granulomatous inflammation of the terminal ileum, establishing Crohn disease as a distinct entity separate from ulcerative colitis and infectious enteritis.

1982 • Marshall & Warren Discover H. pylori

Barry Marshall and Robin Warren identified Helicobacter pylori as the causative agent of most peptic ulcers, overturning decades of belief that ulcers resulted primarily from stress and lifestyle factors. Their work earned the 2005 Nobel Prize.

1998 • Molecular Era of Colorectal Cancer

The elucidation of the adenoma–carcinoma sequence and its genetic underpinnings (APC, KRAS, p53 mutations) solidified the paradigm of stepwise oncogenesis in the colon and transformed screening strategies.

2010s • Microbiome Revolution

High-throughput sequencing revealed the profound influence of the gut microbiome on intestinal immunity, mucosal barrier integrity, and diseases such as inflammatory bowel disease, irritable bowel syndrome, and Clostridioides difficile colitis.

From Beaumont's gastric fistula to the microbiome era, the central question driving GI pathophysiology has remained the same: How do disruptions in mucosal defense, motility, secretion, absorption, and immune regulation produce the clinical syndromes we encounter? The sections that follow will dissect these mechanisms systematically, providing the pathophysiologic framework you need for both clinical reasoning and board examinations.

SECTION 2

Core Principles of GI Pathophysiology

GI pathophysiology can be organized around a set of core principles that recur across nearly every disease category tested on USMLE Step 1. Whether you are analyzing peptic ulcer disease, celiac sprue, or colorectal carcinoma, each condition reflects a perturbation in one or more of these fundamental domains. Mastering these principles provides a framework that allows you to predict clinical presentations, laboratory findings, and complications even for diseases you have not yet formally studied.

Mucosal Barrier Disruption

The GI mucosa serves as a selective barrier separating luminal contents from underlying tissue. Tight junctions, mucus secretion, bicarbonate production, and prostaglandin-mediated cytoprotection maintain this barrier. Disruption leads to acid-peptic disease, increased permeability, and bacterial translocation.

Secretory & Absorptive Dysfunction

The GI tract secretes approximately 7–9 liters of fluid daily and reabsorbs nearly all of it. Perturbation of secretory or absorptive mechanisms produces diarrhea (secretory, osmotic, or mixed), steatorrhea, or malabsorption syndromes.

Motility Disorders

Coordinated peristalsis depends on the enteric nervous system (myenteric and submucosal plexuses), interstitial cells of Cajal, and smooth muscle. Loss of inhibitory neurons (achalasia), myenteric plexus destruction (Chagas), or smooth muscle dysfunction (systemic sclerosis) each produce characteristic motility failures.

Immune Dysregulation

The gut harbors the body's largest immune organ—the gut-associated lymphoid tissue (GALT). Loss of immune tolerance underlies inflammatory bowel disease (Crohn, UC), celiac disease, and food allergies. Conversely, immunodeficiency permits opportunistic infections.

Neoplastic Transformation

The GI epithelium has the highest turnover rate in the body, making it vulnerable to accumulated mutations. The adenoma–carcinoma sequence (APC → KRAS → SMAD4 → p53) and microsatellite instability pathways represent the two major routes to colorectal malignancy.

✦

KEY TAKEAWAY

Think of the GI tract like a city's water treatment system. The mucosal barrier is the filtration membrane, secretion and absorption are the inflow and outflow pipes, motility is the pumping system, and GALT is the quality-control laboratory. A failure in any single component produces a distinct pattern of dysfunction—just as a burst pipe produces a different problem from a failed filter—and clinical reasoning on Step 1 asks you to identify which component has failed based on the presenting pattern.

SECTION 3

Visual Overview — Mucosal Defense & Injury

The balance between aggressive factors (gastric acid, pepsin, reactive oxygen species, H. pylori) and defensive factors (mucus-bicarbonate layer, prostaglandins, mucosal blood flow, epithelial restitution) determines whether the gastric and duodenal mucosa remains intact. The following diagram illustrates this critical equilibrium and the points at which common pathologic insults tip the balance toward mucosal injury.

This diagram shows the balance between aggressive factors (left, red) and defensive factors (right, green) that govern gastric mucosal integrity. The cross-section at the bottom illustrates how the mucus-bicarbonate layer creates a pH gradient from approximately 1–2 in the lumen to near-neutral at the epithelial surface.

The clinical relevance of this diagram is immediately apparent when you consider common exam scenarios. NSAIDs inhibit COX-1, reducing prostaglandin synthesis and thereby diminishing mucus secretion, bicarbonate production, and mucosal blood flow—effectively weakening three defensive lines simultaneously. H. pylori both directly damages the epithelium via CagA and VacA toxins and increases gastric acid output through gastrin hypersecretion in antral-predominant infection. A patient on chronic ibuprofen therapy who also harbors H. pylori thus faces a synergistic assault on mucosal integrity—a common USMLE vignette.

SECTION 4

Mechanisms of Diarrhea & Malabsorption

Diarrhea and malabsorption represent some of the most frequently tested GI pathophysiology topics on Step 1. Understanding the mechanistic classification of diarrhea—secretory, osmotic, inflammatory, and motility-related—is essential because each type has distinctive features in the stool osmotic gap, fasting behavior, and associated laboratory findings. These distinctions inform both diagnosis and targeted therapy.

Stool Osmotic Gap

STOOL OSMOTIC GAP

Stool Osmotic Gap = 290 − 2 × (Stool Na⁺ + Stool K⁺)

A gap > 50 mOsm/kg suggests osmotic diarrhea (unabsorbed solutes are drawing water into the lumen). A gap < 50 mOsm/kg indicates secretory diarrhea (electrolytes dominate stool osmolality because the intestine is actively secreting ions).

Secretory Diarrhea: The Cholera Paradigm

The classic model of secretory diarrhea is Vibrio cholerae infection. Cholera toxin (CT) binds GM1 gangliosides on enterocyte surfaces, and the catalytic A subunit enters the cell where it ADP-ribosylates the Gₛα subunit, permanently activating adenylyl cyclase. The resulting sustained elevation of intracellular cAMP drives CFTR chloride channels on the apical membrane to secrete Cl⁻ into the lumen. Na⁺ and water follow passively, producing the profuse, rice-water stool characteristic of cholera. Importantly, the mucosa remains histologically intact—there is no inflammatory infiltrate or tissue destruction—which is why the stool is watery and non-bloody.

Osmotic Diarrhea: Lactose Intolerance

In lactase deficiency, undigested lactose remains in the intestinal lumen, creating an osmotic load that retains water. Colonic bacteria ferment the lactose, producing short-chain fatty acids, CO₂, and H₂ gas (the basis for the hydrogen breath test). The hallmark of osmotic diarrhea is that it resolves with fasting—removing the offending solute eliminates the osmotic gradient. This fasting response is a key differentiator from secretory diarrhea, which persists even when the patient takes nothing by mouth.

Inflammatory Diarrhea

Inflammatory diarrhea is characterized by mucosal damage with exudation of blood, mucus, and inflammatory mediators into the stool. The prototypes are ulcerative colitis (continuous mucosal inflammation starting at the rectum) and invasive infections such as Shigella or enterohemorrhagic E. coli (EHEC). In ulcerative colitis, crypt abscesses and pseudopolyps reflect the IL-13– and IL-5–driven mucosal immune response that leads to superficial ulceration confined to the mucosa and submucosa. In Crohn disease, the inflammation is transmural and Th1/Th17-mediated, producing non-caseating granulomas, skip lesions, fistulae, and strictures.

💡

HIGH-YIELD DISTINCTION

Secretory diarrhea: large-volume, watery, persists with fasting, low osmotic gap. Osmotic diarrhea: stops with fasting, high osmotic gap. Inflammatory diarrhea: bloody/mucoid stools, elevated fecal leukocytes and lactoferrin. These three distinctions are among the most commonly tested frameworks on Step 1 GI questions.

SECTION 5

Classification of Major GI Pathologies

Step 1 tests a broad range of GI conditions, but these can be organized into functional categories that share underlying pathophysiologic mechanisms. The following diagram and table present a systematic classification that connects etiology, mechanism, and clinical presentation for the most commonly tested entities.

Hierarchical classification of GI pathologies by primary mechanism. Note that many conditions involve overlapping categories—for example, Crohn disease (immune) can produce malabsorption from terminal ileum involvement and carries an increased risk of neoplasia from chronic inflammation.

Category	Prototype Disease	Key Mechanism	Diagnostic Clue
Mucosal Injury	Duodenal ulcer (H. pylori)	↑ acid + ↓ mucosal defense	Epigastric pain relieved by food; positive urea breath test
Motility	Achalasia	Loss of inhibitory neurons (NO/VIP) in myenteric plexus	Dysphagia to solids AND liquids; "bird's beak" on barium swallow
Malabsorption	Celiac disease	Anti-tTG IgA; villous atrophy, crypt hyperplasia, intraepithelial lymphocytes	Steatorrhea, iron deficiency, dermatitis herpetiformis; HLA-DQ2/DQ8
Immune / IBD	Crohn disease	Th1/Th17 transmural inflammation; non-caseating granulomas	Skip lesions, cobblestone mucosa, string sign, fistulae
Neoplasia	Colorectal adenocarcinoma	APC → KRAS → SMAD4 → p53 (chromosomal instability pathway)	Apple-core lesion on barium enema; CEA elevated (monitoring, not screening)

High-yield GI pathologies organized by mechanism

SECTION 6

Worked Example — Clinical Vignette Analysis

Step 1 GI questions typically present a clinical vignette and ask you to identify the underlying pathophysiologic mechanism, the most likely diagnosis, or the expected laboratory/histologic findings. The following worked example demonstrates how to apply the frameworks developed in this lesson to systematically dissect a board-style question.

Vignette: A 58-year-old man with chronic epigastric pain and weight loss

1
Step 1 — Extract Key Clinical Features

A 58-year-old man presents with a 6-month history of burning epigastric pain that worsens with meals. He reports early satiety, a 15-pound unintentional weight loss, and intermittent nausea. He has a 30-year history of GERD and has taken over-the-counter antacids intermittently. On exam, a palpable supraclavicular lymph node is noted on the left (Virchow node). CBC reveals a microcytic anemia (Hgb 9.2 g/dL, MCV 72 fL).

Key features: chronic GERD, epigastric pain worsened by meals, weight loss, Virchow node, microcytic anemia
2
Step 2 — Identify the Pathophysiologic Category

The combination of weight loss, left supraclavicular lymphadenopathy, and microcytic anemia in the setting of chronic GERD points strongly toward a neoplastic process rather than simple acid-peptic disease. Pain worsened by meals (as opposed to the pain relieved by meals in duodenal ulcers) further suggests gastric pathology. Virchow node specifically drains the thoracic duct and is classically associated with GI malignancies.

Category: Neoplasia (gastric carcinoma)
3
Step 3 — Connect to Pathophysiologic Mechanism

Chronic GERD can lead to Barrett esophagus (intestinal metaplasia of the lower esophagus), which increases risk for esophageal adenocarcinoma. However, this patient's pain pattern and physical findings localize the lesion to the stomach. Chronic gastritis from H. pylori (which can coexist with GERD) drives the metaplasia → dysplasia → carcinoma sequence in the stomach. The intestinal type of gastric adenocarcinoma follows the Correa cascade: chronic gastritis → atrophic gastritis → intestinal metaplasia → dysplasia → carcinoma.

Mechanism: Correa cascade (chronic H. pylori gastritis → intestinal metaplasia → gastric adenocarcinoma)
4
Step 4 — Predict Expected Findings

Histology would show signet-ring cells (if diffuse type) or glandular structures with dysplasia (if intestinal type). The microcytic anemia reflects chronic occult blood loss from the tumor. The Virchow node represents left supraclavicular metastasis via the thoracic duct. EGD with biopsy is the diagnostic test of choice. Tumor markers like CEA may be elevated but are not used for screening.

Diagnosis: Gastric adenocarcinoma (intestinal type), most likely associated with chronic H. pylori gastritis and the Correa cascade

🔑

CLINICAL REASONING TIP

On Step 1 vignettes, always ask three questions in sequence: (1) Which organ is affected? (2) Which pathophysiologic category (mucosal injury, motility, malabsorption, immune, neoplasia) best fits the presentation? (3) What is the specific molecular or cellular mechanism? This hierarchical approach prevents you from jumping to a diagnosis before understanding the underlying pathophysiology, which is precisely what the exam is testing.

SECTION 7

Crohn Disease vs. Ulcerative Colitis — A Critical Comparison

Differentiating Crohn disease from ulcerative colitis is one of the most frequently tested comparisons in GI pathophysiology. Although both are forms of inflammatory bowel disease with a relapsing-remitting course, they differ fundamentally in the location, depth, histologic pattern, and complications of inflammation. The following table consolidates the key distinguishing features that are most commonly targeted on board examinations.

Feature	Crohn Disease	Ulcerative Colitis
Location	Mouth to anus (terminal ileum most common); skip lesions	Colon only; continuous, starting at rectum, extending proximally
Depth	Transmural	Mucosa & submucosa only
Histology	Non-caseating granulomas; lymphoid aggregates	Crypt abscesses; crypt distortion; no granulomas
Gross appearance	Cobblestone mucosa, creeping fat, strictures	Pseudopolyps, friable mucosa, lead-pipe colon on imaging
Immune profile	Th1/Th17 predominant; ↑ TNF-α, IL-12, IL-23	IL-13 and IL-5 predominant (NKT cell–driven); ↑ IL-13, IL-5
Complications	Fistulae, abscesses, strictures, B₁₂/bile salt malabsorption, kidney stones (oxalate)	Toxic megacolon, ↑ colorectal cancer risk, primary sclerosing cholangitis (PSC)
Serology	ASCA positive	p-ANCA positive
Smoking	Worsens disease	Protective (counterintuitive)
Surgery	Not curative (recurs at anastomosis)	Curative with total proctocolectomy

Crohn Disease vs. Ulcerative Colitis — High-Yield Board Comparison

💡

MNEMONIC AID

Remember: Crohn = Creeping fat, Cobblestones, skip lesions, fistulae, and Granulomas (all start with C or G). Ulcerative colitis = Continuous from the rectum, Crypt abscesses, Colon only, Curable by colectomy. The transmural nature of Crohn disease explains why it forms fistulae (the inflammation burrows through the full thickness of the wall), while UC's superficial inflammation explains why it causes bleeding and friable mucosa but not fistulae.

SECTION 8

Connection to Advanced Concepts — Hepatobiliary & Pancreatic Interactions

GI pathophysiology does not exist in isolation. The hepatobiliary system and exocrine pancreas are intimately linked to intestinal function, and many board questions test your ability to trace pathophysiology across organ boundaries. For instance, terminal ileum disease (Crohn) disrupts the enterohepatic circulation of bile salts, producing fat malabsorption and gallstone formation—a connection that bridges GI and hepatobiliary pathophysiology. Understanding these cross-system interactions prepares you for the integrative clinical reasoning demanded on Step 1 and Step 2.

GI Concept	Advanced Integration	Clinical Significance
Terminal ileum resection / Crohn disease	Bile salt malabsorption → decreased bile salt pool → impaired fat digestion; unabsorbed bile salts in colon → secretory diarrhea	Steatorrhea, fat-soluble vitamin deficiency (A, D, E, K), cholesterol gallstones, oxalate kidney stones
Celiac disease	Villous atrophy → ↓ CCK and secretin release → ↓ pancreatic enzyme and bile secretion → worsening malabsorption	Iron deficiency (duodenal absorption), osteoporosis (↓ Ca²⁺, ↓ vitamin D), dermatitis herpetiformis
Chronic pancreatitis	Exocrine insufficiency → ↓ lipase, amylase, proteases → luminal maldigestion	Steatorrhea (fat maldigestion, not malabsorption), calcifications on CT, diabetes (endocrine loss)
Portal hypertension (cirrhosis)	Elevated portal pressure → esophageal/gastric varices, hemorrhoids, caput medusae; portal-systemic shunting → hepatic encephalopathy	Variceal bleeding, ascites, spontaneous bacterial peritonitis, hepatorenal syndrome
Adenoma–carcinoma sequence	Chromosomal instability (CIN) pathway: APC → KRAS → SMAD4 → p53; Microsatellite instability (MSI): DNA mismatch repair defects (Lynch syndrome)	CRC screening guidelines, genetic testing for Lynch, chemoprevention with aspirin in high-risk patients

Cross-System Pathophysiologic Connections

As you advance into clinical medicine, you will find that the mechanistic frameworks developed in this lesson—mucosal defense, secretory physiology, motility regulation, immune homeostasis, and stepwise oncogenesis—serve as the conceptual backbone for understanding not only GI diseases but also their systemic manifestations and complications. For example, understanding that Crohn disease is Th1/Th17-mediated helps explain its extraintestinal manifestations (erythema nodosum, uveitis, seronegative arthritis) as systemic manifestations of the same immune dysregulation. This systems-level thinking is what distinguishes high-performing examinees from those who merely memorize isolated facts.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A 28-year-old man presents to the emergency department after returning from a trip to rural Bangladesh. He reports 12 hours of profuse, watery diarrhea described as "rice-water" stools, with no blood or mucus. He has had six large-volume bowel movements since symptom onset and notes that the diarrhea has not slowed despite being unable to eat for the past 8 hours. Temperature is 37.2°C, blood pressure is 98/62 mmHg, heart rate is 114 bpm, and skin turgor is markedly reduced. Stool electrolytes are sent: stool [Na⁺] = 130 mEq/L, stool [K⁺] = 15 mEq/L, and measured stool osmolality = 290 mOsm/kg. Which of the following best describes the category and underlying pathophysiologic mechanism responsible for this patient's diarrhea? (A) Osmotic diarrhea — unabsorbed solutes draw water into the lumen; resolves with fasting (B) Secretory diarrhea — active ion secretion driven by elevated intracellular second messengers causes water loss independent of oral intake (C) Inflammatory diarrhea — mucosal injury leads to exudation of protein, blood, and immune cells into the lumen (D) Motility-related diarrhea — rapid intestinal transit reduces contact time for absorption

Show answer

The correct answer is (B) Secretory diarrhea — active ion secretion driven by elevated intracellular second messengers causes water loss independent of oral intake. Step-by-step verification: 1. Calculate the stool osmotic gap: 290 − 2 × (stool [Na⁺] + stool [K⁺]) = 290 − 2 × (130 + 15) = 290 − 290 = 0 mOsm/kg. A gap < 50 mOsm/kg confirms secretory diarrhea; a gap > 125 mOsm/kg would indicate osmotic diarrhea. The gap here is essentially 0, strongly confirming secretory diarrhea — stool osmolality is fully accounted for by electrolytes alone. 2. Persistence with fasting: In osmotic diarrhea, removing the offending solute by fasting resolves the diarrhea. The fact that diarrhea continues unabated despite 8 hours of fasting rules out choice (A). 3. Absence of blood, mucus, or signs of mucosal damage: The "rice-water" stool description and lack of any bloody or purulent components rules out inflammatory/exudative diarrhea, eliminating choice (C). 4. Large-volume, not motility-driven: The massive stool volumes and the absence of any clinical features suggesting rapid transit or dysmotility (e.g., post-vagotomy, hyperthyroidism) rule out choice (D). 5. Pathophysiologic mechanism: Cholera toxin (from Vibrio cholerae, a classic pathogen in Bangladesh) permanently activates Gs-protein by ADP-ribosylating its alpha subunit, locking adenylyl cyclase in the "on" position. This markedly elevates intracellular cAMP in enterocytes, which activates protein kinase A. PKA phosphorylates and opens CFTR Cl⁻ channels at the apical membrane, driving Cl⁻ secretion into the lumen. Simultaneously, PKA inhibits Na⁺/H⁺ and Cl⁻/HCO₃⁻ exchangers, reducing NaCl absorption. Water follows the secreted ions passively down the osmotic gradient, producing the characteristic high-volume, isotonic, rice-water diarrhea. Because the mechanism is entirely toxin-mediated and not dependent on luminal nutrients, fasting does not reduce stool output — the hallmark of secretory diarrhea.

Question 2: BASIC CALCULATION

A stool sample returns with Na⁺ = 40 mEq/L and K⁺ = 30 mEq/L. Calculate the stool osmotic gap using a serum osmolality of 290 mOsm/kg. Classify the diarrhea type based on this result.

Show answer

Stool osmotic gap = 290 − 2 × (40 + 30) = 290 − 2 × 70 = 290 − 140 = 150 mOsm/kg. A stool osmotic gap > 50 mOsm/kg indicates osmotic diarrhea. The large gap means that unmeasured, non-electrolyte solutes (such as undigested lactose, sorbitol, or magnesium-containing laxatives) are present in the stool and are drawing water osmotically. This diarrhea would be expected to improve or resolve with fasting. Common causes include lactase deficiency, celiac disease, and osmotic laxative use.

Question 3: INTERMEDIATE

A 35-year-old woman presents with 6 months of intermittent bloody diarrhea, tenesmus, and crampy lower abdominal pain. Colonoscopy reveals continuous erythematous, friable mucosa extending from the rectum to the splenic flexure, with crypt abscesses on biopsy. She also has primary sclerosing cholangitis. What is the most likely diagnosis, and which immune pathway predominantly drives this condition?

Show answer

The diagnosis is ulcerative colitis (UC). The key features include: (1) continuous (not skip) inflammation starting at the rectum and extending proximally, (2) involvement limited to the colon, (3) crypt abscesses on histology without granulomas, and (4) association with primary sclerosing cholangitis (PSC), which is specifically associated with UC rather than Crohn disease. UC is driven primarily by an IL-13– and IL-5–driven mucosal immune response involving NKT cells, producing superficial mucosal and submucosal inflammation. The p-ANCA serologic marker is often positive. Unlike Crohn disease, UC can be cured by total proctocolectomy.

Question 4: APPLIED

A 28-year-old man with Crohn disease affecting the terminal ileum undergoes a 100-cm ileal resection. Six months later, he develops steatorrhea and recurrent calcium oxalate kidney stones. Explain the pathophysiologic connection between his ileal resection, fat malabsorption, and nephrolithiasis.

Show answer

The terminal ileum is the exclusive site for active bile salt reabsorption in the enterohepatic circulation. Loss of 100 cm of ileum means bile salts are not recycled and pass into the colon, depleting the bile salt pool below the critical micellar concentration needed for fat emulsification. This produces steatorrhea (fat malabsorption). The unabsorbed fatty acids in the intestinal lumen bind to calcium, forming fatty acid–calcium soaps. Normally, calcium binds to dietary oxalate in the gut lumen, preventing oxalate absorption. With calcium sequestered by fatty acids, free oxalate is absorbed in excess from the colon, enters the blood, is filtered by the kidneys, and precipitates with urinary calcium to form calcium oxalate stones. This is termed enteric hyperoxaluria and is a classic complication of ileal resection or ileal Crohn disease. Management includes a low-fat, low-oxalate diet and calcium supplementation to bind oxalate in the gut.

Question 5: CRITICAL THINKING

A researcher discovers a family with autosomal dominant inheritance of colorectal cancer, with affected members developing cancer at a mean age of 44. Tumors show high microsatellite instability (MSI-H) and loss of MLH1 protein expression on immunohistochemistry. Compare and contrast the molecular pathogenesis of this familial syndrome with the sporadic adenoma–carcinoma sequence (chromosomal instability pathway). How does understanding these two pathways inform screening and treatment strategies?

Show answer

This family has Lynch syndrome (hereditary nonpolyposis colorectal cancer, HNPCC), caused by germline mutations in DNA mismatch repair (MMR) genes—in this case, MLH1. The MSI pathway accumulates errors in microsatellite repeat sequences because the cell cannot correct replication slippage, leading to frameshift mutations in tumor suppressor genes like BAX and TGF-β receptor II. Tumors tend to arise from flat adenomas, are often right-sided, have a better prognosis stage-for-stage, and respond well to immune checkpoint inhibitors due to their high neoantigen load. By contrast, the sporadic chromosomal instability (CIN) pathway follows the Vogelstein model: APC loss (early adenoma) → KRAS activation (intermediate adenoma) → SMAD4 loss → p53 loss (carcinoma). These tumors tend to be left-sided, arise from polypoid adenomas, and have aneuploidy rather than MSI. Screening implications differ substantially: Lynch syndrome patients require colonoscopy starting at age 20–25 (or 2–5 years before the youngest diagnosis in the family) every 1–2 years, whereas average-risk screening for CIN-pathway cancers begins at age 45 every 10 years. Treatment implications include the use of pembrolizumab or nivolumab for MSI-H tumors, highlighting how molecular characterization directly guides therapy.

SUMMARY

Lesson Summary

Summary

Gastrointestinal pathophysiology encompasses five interconnected domains: mucosal barrier disruption (peptic ulcer disease, GERD, NSAID gastropathy), secretory and absorptive dysfunction (secretory vs. osmotic diarrhea, celiac disease, tropical sprue), motility disorders (achalasia, Hirschsprung disease, gastroparesis), immune dysregulation (Crohn disease with Th1/Th17 transmural inflammation versus ulcerative colitis with IL-13– and IL-5–driven mucosal inflammation), and neoplastic transformation via either the chromosomal instability pathway (APC → KRAS → SMAD4 → p53) or the microsatellite instability pathway (Lynch syndrome).

The stool osmotic gap distinguishes secretory (< 50, persists with fasting) from osmotic (> 50, resolves with fasting) diarrhea. H. pylori drives peptic ulcer disease through urease, CagA, and VacA toxins, while NSAIDs impair mucosal defense by inhibiting COX-1-dependent prostaglandin synthesis. Cross-system connections—such as bile salt malabsorption from ileal disease causing steatorrhea and enteric hyperoxaluria—demonstrate the integrative reasoning that Step 1 demands. Mastering these mechanistic frameworks allows you to approach any GI vignette systematically rather than relying on pattern recognition alone.